Cargando…
P2 Receptors: Novel Disease Markers and Metabolic Checkpoints in Immune Cells
Extracellular ATP (eATP) and P2 receptors are novel emerging regulators of T-lymphocyte responses. Cellular ATP is released via multiple pathways and accumulates at sites of tissue damage and inflammation. P2 receptor expression and function are affected by numerous single nucleotide polymorphisms (...
Autores principales: | Vultaggio-Poma, Valentina, Di Virgilio, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313346/ https://www.ncbi.nlm.nih.gov/pubmed/35883539 http://dx.doi.org/10.3390/biom12070983 |
Ejemplares similares
-
P2X7: a receptor with a split personality that raises new hopes for anti-cancer therapy
por: Sarti, Alba Clara, et al.
Publicado: (2021) -
The Coming of Age of the P2X7 Receptor in Diagnostic Medicine
por: Di Virgilio, Francesco, et al.
Publicado: (2023) -
Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation
por: Di Virgilio, Francesco, et al.
Publicado: (2018) -
Unorthodox localization of P2X7 receptor in subcellular compartments of skeletal system cells
por: Penolazzi, Letizia, et al.
Publicado: (2023) -
Extracellular ATP: A Feasible Target for Cancer Therapy
por: Vultaggio-Poma, Valentina, et al.
Publicado: (2020)